Traws Pharma logo

Traws Pharma Share Price Today

(NASDAQ: TRAW)

Traws Pharma share price is $2.6 & ₹226.12 as on 6 Mar 2025, 2.30 'hrs' IST

$2.6

0.21

(8.79%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Traws Pharma share price in Dollar and Rupees. Guide to invest in Traws Pharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Traws Pharma, along with analyst recommendations, forecasts, and comprehensive financials.

Traws Pharma share price movements

  • Today's Low: $2.40
    Today's High: $2.69

    Day's Volatility :10.78%

  • 52 Weeks Low: $2.24
    52 Weeks High: $24.75

    52 Weeks Volatility :90.94%

Traws Pharma (TRAW) Returns

PeriodTraws Pharma, Inc.Index (Russel 2000)
3 Months
-52.62%
0.0%
6 Months
-72.99%
0.0%
1 Year
-88.84%
0.0%
3 Years
-88.84%
-11.6%

Traws Pharma (TRAW) Key Statistics

in dollars & INR

Previous Close
$2.39
Open
$2.55
Today's High
$2.69
Today's Low
$2.4
Market Capitalization
$8.4M
Today's Volume
$10.7K
52 Week High
$24.75
52 Week Low
$2.2416
Revenue TTM
$226.0K
EBITDA
$-24.1M
Earnings Per Share (EPS)
$-135.78
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-2255.45%

How to invest in Traws Pharma Stock (TRAW) from India?

It is very easy for Indian residents to invest directly in Traws Pharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Traws Pharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Traws Pharma or TRAW on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Traws Pharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Traws Pharma shares which would translate to 0.334 fractional shares of Traws Pharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Traws Pharma, in just a few clicks!

Returns in Traws Pharma (TRAW) for Indian investors in Rupees

The Traws Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Traws Pharma investment value today

Current value as on today

₹17,101

Returns

₹82,899

(-82.9%)

Returns from Traws Pharma Stock

₹87,862 (-87.86%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Traws Pharma (TRAW)

-34%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Traws Pharma Stock from India on INDmoney has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Traws Pharma

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Traws Pharma(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Traws Pharma Stock (TRAW)

What analysts predicted

Upside of 150.0%

Target:

$6.50

Current:

$2.60

Insights on Traws Pharma Stock (Ticker Symbol: TRAW)

  • Price Movement

    In the last 7 days, TRAW stock has moved down by -31.7%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 56.0K → 57.0K (in $), with an average increase of 0.9% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -123.14M → -8.47M (in $), with an average increase of 1353.0% per quarter

Traws Pharma Technicals Summary

Sell

Neutral

Buy

Traws Pharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Traws Pharma (TRAW) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Traws Pharma, Inc. logo
-68.84%
-72.99%
-88.84%
-88.84%
-88.84%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Traws Pharma, Inc. logo
NA
NA
NA
0.0
-22.55
-0.84
NA
-0.67
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Traws Pharma, Inc. logo
Buy
$8.4M
-88.84%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Traws Pharma

Traws Pharma, Inc., a clinical stage biopharmaceutical company, focuses on developing small molecule oral product candidates for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID19 that are designed to address treatment resistance, such as TRX01 (travatrelvir), a Mpro/3CL inhibitor in development for the treatment of COVID19; and TRX100 (viroxavir), an endonuclease inhibitor in development for the treatment of pandemic influenza. It is also developing narazaciclib, a multi-kinase CDK4/6 inhibitor, which is in Phase 1/2 clinical trials in patients with cancer, with or without co-administration of letrozole to define the recommended phase 2 dose for further development in endometrial cancer; and oral rigosertib, which is administered alone or in combination for investigation in various cancers. The company was formerly known as Onconova Therapeutics, Inc. and changed its name to Traws Pharma, Inc. in April 2024. Traws Pharma, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.
Organization
Traws Pharma
Employees
17
CEO
Dr. Werner Cautreels Ph.D.
Industry
Miscellaneous

Management People of Traws Pharma

NameTitle
Dr. Victor Moyo M.D.
Chief Medical Officer of Oncology
Dr. Iain D. Dukes DPHIL, M.A., Ph.D.
Executive Chairman
Dr. Werner Cautreels Ph.D.
CEO & Director
Ms. Nora E. Brennan
Interim Chief Financial Officer
Dr. Nikolay Savchuk Ph.D.
COO & Director
Dr. Robert R. Redfield M.D.
Chief Medical Officer
Dr. Charles David Pauza Ph.D.
Chief Scientific Officer of Virology

Important FAQs about investing in TRAW Stock from India :

What is Traws Pharma share price today?

Traws Pharma share price today stands at $2.60, Open: $2.55 ; Previous Close: $2.39 ; High: $2.69 ; Low: $2.40 ; 52 Week High: $24.75 ; 52 Week Low: $2.24.

The stock opens at $2.55, after a previous close of $2.39. The stock reached a daily high of $2.69 and a low of $2.40, with a 52-week high of $24.75 and a 52-week low of $2.24.

Can Indians buy Traws Pharma shares?

Yes, Indians can invest in the Traws Pharma (TRAW) from India.

With INDmoney, you can buy Traws Pharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Traws Pharma at zero transaction cost.

How can I buy Traws Pharma shares from India?

It is very easy to buy Traws Pharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Traws Pharma (TRAW) be purchased?

Yes, you can buy fractional shares of Traws Pharma with INDmoney app.

What are the documents required to start investing in Traws Pharma stocks?

To start investing in Traws Pharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Traws Pharma Stock (TRAW)?

Today’s highest price of Traws Pharma (TRAW) is $2.69.

Today’s lowest price of Traws Pharma (TRAW) is $2.40.

What is today's market capitalisation of Traws Pharma?

Today's market capitalisation of Traws Pharma TRAW is 8.4M

What is the 52 Week High and Low Range of Traws Pharma Stock (TRAW)?

  • 52 Week High

    $24.75

  • 52 Week Low

    $2.24

What are the historical returns of Traws Pharma (TRAW)?

  • 1 Month Returns

    -68.84%

  • 3 Months Returns

    -72.99%

  • 1 Year Returns

    -88.84%

  • 5 Years Returns

    -88.84%

Who is the Chief Executive Officer (CEO) of Traws Pharma ?

Dr. Werner Cautreels Ph.D. is the current Chief Executive Officer (CEO) of Traws Pharma.